Aquablation in Benign Prostatic Hyperplasia in Canada

Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).

To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.

Patients will be followed up for 3 years as standard of care.

Inclusion Criteria:

• Primary diagnosis of Benign Prostate Hypertrophy (BPH)
• Male subjects of ≥ 18 years of age
• Candidate for Aquablation therapy as per clinical decision of Investigator
• Willing and able to accurately complete questionnaires
• Willing and able to provide signed and dated informed consent

Exclusion Criteria:

• Characteristics indicating a poor compliance with study protocol requirements.
• Disease or other health condition that is not suitable for this study.
• Unable or unwilling to provide signed informed consent.